Kun læger med erfaring i immunsuppressiv behandling og behandling af organtransplanterede patienter bør ordinere lægemidlet og initiere ændringer i den immunsuppressive behandling.
The medicinal product should only be prescribed, and changes in immunosuppressive therapy initiated, by physicians experienced in immunosuppressive therapy and the management of transplant patients.